Henry Schein Inc (HSIC) Stock Price & Analysis
Henry Schein Inc (HSIC) fell 1.16% to USD 89.81 as of September 8, 2026 at 04:20 UTC, according to Nexqual real-time market data.
HSIC last closed at USD 89.81; the session ranged USD 89.65–90.54 on volume of 887,873 shares. Market capitalization is —, with a 52-week range of USD 61.95–92.18 (NMS). Source: Nexqual, September 8, 2026 at 04:20 UTC.
Key Statistics (as of September 8, 2026 at 04:20 UTC)
| Price | USD 89.81 |
|---|---|
| Change | ▼ 1.16% (down) |
| Previous Close | USD 89.81 |
| Open | USD 89.81 |
| Day Range | USD 89.65 – 90.54 |
| 52-Week Range | USD 61.95 – 92.18 |
| Volume | 887,873 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (HSIC)
Nexqual's technical model rates HSIC "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 04:20 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 55.22 (neutral) |
| vs SMA50 | Above (USD 87.43) |
| MACD | 0.86 (positive) |
From Henry Schein Inc's Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Our infrastructure, including over 5.4 million square feet of space in 38 strategically located distribution centers and 0.6 million square feet of space in 17 manufacturing facilities around the world, enables us to historically provide rapid and accurate order fulfillment, better serve our customers and increase our operating efficiency.
- Within Global Technology, we compete against numerous dental software providers, including the Eaglesoft division of Patterson Companies, Inc., Carestream Dental LLC, Centaur Software Development Co Pty Ltd. (d.b.a. dental4windows, dental4web), Open Dental Software, Inc., PlanetDDS LLC, Good Methods Global Inc. (d.b.a.
- We offer a broad range of products, including the Henry Schein corporate brand, and services to our customers at competitive prices, in the following categories: Global Distribution and Value-Added Services • Consumable merchandise and equipment.
- Furthermore, Section 361 of the Public Health Service Act, which provides authority to prevent the introduction, transmission or spread of communicable diseases, serves as the legal basis for the United States Food and Drug Administration's ("FDA") regulation of human cells, tissues and cellular and tissue-based products, also known as "HCT/P products." The Federal Drug Quality and Security Act of 2013 regulates pharmaceutical supply chain requirements and pre- empts certain state laws.
Partnerships
- In collaboration with leading clinicians, our research and development teams drive innovation to enhance patient care.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XRAY | DENTSPLY SIRONA Inc. | USD 11.38 | ▲ 0.8% |
| COO | The Cooper Companies, Inc. | USD 69.59 | ▼ 0.2% |
| UHS | Universal Health Services, Inc. | USD 169.65 | ▲ 1.29% |
| MTD | Mettler-Toledo International, I | USD 1,345.26 | ▼ 1.64% |
| CHRW | C.H. Robinson Worldwide, Inc. | USD 147.64 | ▲ 1.68% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:20 UTC. This page is informational and not investment advice.